Skip to main content
Getinge logo

Getinge — Investor Relations & Filings

Ticker · GETI ISIN · SE0000202624 LEI · 5493003PZ4F570G3W735 ST Manufacturing
Filings indexed 648 across all filing types
Latest filing 2022-06-30 Board/Management Inform…
Country SE Sweden
Listing ST GETI

Getinge is a global medical technology company that provides products and solutions for hospitals and life science institutions. The company's offerings are designed to improve clinical outcomes and support healthcare professionals. Its portfolio is focused on three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Key products include equipment and systems for intensive care, cardiovascular procedures, operating rooms, and sterile reprocessing. Notable solutions feature advanced ventilators like the Servo-u, extracorporeal life support systems such as Cardiohelp II, and equipment for biopharmaceutical production. The company also offers training and educational services to enhance clinical expertise.

Recent filings

Filing Released Lang Actions
Lena Hagman, Executive Vice President Quality compliance, Regulatory & Medical Affairs lämnar Getinge
Board/Management Information Classification · 100% confidence The document is a press release dated June 30, 2022, announcing that Lena Hagman, Executive Vice President Quality compliance, Regulatory & Medical Affairs, is leaving Getinge. This announcement concerns a change in senior management/executive leadership. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is clearly an announcement of an executive departure, fitting the MANG category perfectly.
2022-06-30 Swedish
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document details a change in shareholding and voting rights for a specific holder (AMF Tjänstepension AB) in an issuer (Getinge AB). It explicitly shows the 'Before the transaction' and 'After the transaction' quantities of shares and voting rights, including direct and indirect holdings, and the resulting percentage change. This structure is characteristic of a notification regarding changes in significant share ownership, which aligns with the definition for Major Shareholding Notification (MRQ). The document is a direct report of the transaction, not an announcement of a report.
2022-06-22 English
Getinge justerar ner prognos för 2022 – långsiktiga finansiella mål oförändrade
Earnings Release Classification · 99% confidence The document is a press release dated June 14, 2022, titled "Getinge adjusts 2022 forecast down – long-term financial targets unchanged." It discusses changes to the organic net sales growth forecast for 2022 due to external challenges (mild flu season, reduced vaccine manufacturing, supply chain issues, etc.) and mentions the expected negative impact on the EBITA margin. Crucially, it states: "Getinge will publish its quarterly report for January-June 2022 on July 19, 2022." This document is an announcement revising guidance/outlook, not the actual quarterly report (IR) or the full annual report (10-K). It is a pre-release communication regarding financial expectations. Since it is a financial update that is not a formal earnings release (ER, which is usually the initial release of results), and it is not a presentation (IP) or a management discussion (MDA), the most fitting category for a significant financial outlook adjustment announced via press release is often classified under general Regulatory Filings (RNS) or sometimes treated as a precursor to an Earnings Release (ER). However, given the content is purely about adjusting the financial outlook/guidance, it is a specific type of financial news. Since there is no specific code for 'Guidance Update', and it is not the formal 'Earnings Release' (ER) which typically contains the actual period results, it falls best under the general 'Regulatory Filings' (RNS) as a mandatory market disclosure under EU MAR, or potentially as a precursor to the ER. Given the context of financial updates, and that it is a formal press release announcing financial expectations rather than the actual results, RNS is the safest fallback for a non-standard financial announcement. If 'Guidance Update' existed, that would be preferred. Comparing it to the definitions, it is not an ER (which releases results), nor an MDA (which is management's detailed explanation *of* results). Therefore, RNS is the appropriate fallback for this specific type of market-sensitive financial announcement. FY 2022
2022-06-14 Swedish
Getinge revises down its outlook for 2022 – long-term financial targets unchanged
Earnings Release Classification · 99% confidence The document is titled "Press release" and announces a revision to the company's 2022 outlook, detailing reasons for the change (external challenges, demand shifts) and confirming long-term targets remain unchanged. It explicitly states when the next comprehensive report (Interim Report January – June 2022) will be published. Crucially, it announces a conference call to discuss these results/revisions and provides links to access a presentation. Since this document is an initial announcement of financial performance changes (outlook revision) and includes details about an accompanying presentation and conference call, it strongly aligns with the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results (key highlights only). It is not the full Interim Report (IR) itself, nor is it a transcript (CT) or a formal presentation (IP), but the announcement preceding them. FY 2022
2022-06-14 English
Resolutions at Getinge’s Annual General Meeting 26 April 2022
AGM Information Classification · 99% confidence The document is explicitly titled 'Resolutions at Getinge's Annual General Meeting 26 April 2022' and details the outcomes of the AGM, such as the adoption of financial statements, dividend declaration, election/re-election of Board members, auditor appointment, and approval of remuneration reports and guidelines. This content directly corresponds to the materials presented or resolved upon during an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-04-26 English
Beslut vid Getinges årsstämma den 26 april 2022
AGM Information Classification · 98% confidence The document is titled "Beslut vid Getinges årsstämma den 26 april 2022" (Decisions at Getinge's Annual General Meeting on April 26, 2022) and details the resolutions passed, such as approving the 2021 financial statements, declaring a dividend, approving director remuneration, electing the board, and approving remuneration guidelines. These are the core components of an Annual General Meeting (AGM) outcome announcement. Since the document explicitly reports the decisions made at the AGM, the most appropriate classification is AGM Information (AGM-R). It is not a proxy statement (PSI) as it reports the results, nor is it a full 10-K or IR report.
2022-04-26 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.